Shape optimization and characterization of polysaccharide beads prepared by ionotropic gelation

References

• Bajpai SK, Sharma S. Investigation of swelling/degradation behaviour of alginate beads crosslinked with Ca2+ and Ba2+ ions. React Funct Polym 2004; 59: 129–140
   Web of Science ®Google Scholar
• Bogataj M, Mrhar A, Lavrič A. 2005, Černe M, Tibaut D, Štalc A, Urleb U, Mateovič T, Cof G, Kerč J, Dreu R, Yoneda F, Muraoka S. 2005. Gastroresistant pharmaceutical dosage form comprinsing N-(2-(2-phthalimidoethoxy-)acetyl)-L-alanyl-D-glutamic acid (LK-423). Patent WO 2005/092295 A1, 10 October
   Google Scholar
• Chourasia MK, Jain SK. Polysaccharides for colon target drug delivery. Drug Deliv 2004; 11: 129–148
   PubMed Web of Science ®Google Scholar
• El-Kamel AH, Al-Gohary OMN, Hosny EA. Alginate-diltiazem hydrocloride beads: optimization of formulation factors, in vitro and in vivo bioavailability. J Microencapsulation 2003; 20: 211–225
   PubMed Web of Science ®Google Scholar
• Fereira Almeida P, Almeida AJ. Cross-linked alginate-gelatine beads: A new matrix for controlled release of pindolol. J Control Rel 2004; 97: 431–439
   PubMedGoogle Scholar
• Fundueanu G, Nastruzzi C, Carpov A, Desbrieres J, Rinaudo M. Physico-chemical characterization of Ca-alginate microparticles produced with different methods. Biomaterials 1999; 20: 1427–1435
   PubMed Web of Science ®Google Scholar
• Gal A, Nussinovitch A. Hydrocolloid carriers with filler inclusion for diltiazem hydrochloride release. J Pharm Sci 2007; 96: 168–178
   PubMed Web of Science ®Google Scholar
• Garcia AM, Ghaly ES. Preliminary spherical agglomerates of water soluble drug using natural polymer and cross-linking technique. J Control Rel 1996; 40: 179–186
   Web of Science ®Google Scholar
• Gombotz WR, Wee SF. Protein release from alginate matrices. Adv Drug Deliv Rev 1998; 31: 267–285
   PubMed Web of Science ®Google Scholar
• González-Rodríguez ML, Holgado MA, Sánchez-Lafuente C, Rabasco AM, Fini A. Alginate/chitosan particulate systems for sodium diclofenac release. Int J Pharm 2002; 232: 225–234
   PubMed Web of Science ®Google Scholar
• Kedzierewicz F, Lombry C, Rios R, Hoffman M, Maincent P. Effect of the formulation on the in-vitro release of propranolol from gellan beads. Int J Pharm 1999; 178: 129–136
   PubMed Web of Science ®Google Scholar
• Moriguchi M, Urabe K, Norisada N, Ochi C, Stalc A, Urleb U, Muraoka S. Therapeutic effect of LK 423, a phthalimido-desmuramyl-dipeptide compound, on dextran sulfate sodium—induced colitis in rodents through restoring their interleukin-10 producing capacity. Arzneimittle-Forschung/Drug Res 1999; 49: 184–192
   Google Scholar
• Nafisi S, Shamloo DS, Mohajerani N, Omidi A. A comparative study of caffeine and theophylline binding to Mg(II) and Ca(II) ions: Studied by FTIR and UV spectroscopic methods. J Molec Struct 2002; 608: 1–7
   Google Scholar
• Nakamura K, Nishimura Y, Hatakeyama T, Hatakeyama H. Thermal properties of water insoluble alginate films containing di- and trivalent cations. Thermochim Acta 1995; 267: 343–353
   Web of Science ®Google Scholar
• Noveon Inc. Formulating topical properties. Bulletin 14 [serial online]. 2002, Available online at: http://www.pharma.noveon.com/Bulletins/epb14.pdf, accessed 27 March 2007
   Google Scholar
• Ochi C, Norisada N, Moriguchi M, Stalc A, Urleb U, Muraoka S. Interleukin-10 inducing activity of LK423, a phthalimido-desmuramyldipepdide compound. Arzneimittle-forschung/Drug Res 1999; 49: 71–79
   Google Scholar
• Østberg T, Lund EM, Graffner C. Calcium alginate matrices for oral multiple unit administration: IV. Release characteristics in different media. Int J Pharm 1994; 112: 241–248
   Web of Science ®Google Scholar
• Østberg T, Vesterhus L, Graffner C. Calcium alginate matrices for oral multiple unit administration: II. Effect of process and formulation factors on matrix properties. Int J Pharm 1993; 97: 183–193
   Web of Science ®Google Scholar
• Pongjanyakul T, Puttipipatkhachorn S. Xanthan-alginate composite gel beads: Molecular interactions and in vitro characterization. Int J Pharm 2007; 331: 61–71
   PubMed Web of Science ®Google Scholar
• Puttipipatkhachorn S, Pongjanyakul T, Priprem A. Molecular interactions in alginate beads reinforced with sodium starch glycolate or magnesium silicate, and their physical characteristics. Int J Pharm 2005; 293: 51–62
   PubMed Web of Science ®Google Scholar
• Rousseau I, Le Cerf D, Picton L, Argillier JF, Muller G. Entrapment and release of sodium polystyrene sulfonate (SPS) from calcium alginate gel beads. Eur Polym J 2004; 40: 2709–2715
   Web of Science ®Google Scholar
• Sartori C, Finch DS, Ralph B, Gilding K. Determination of the cation content of alginate thin films by FTi.r. spectroscopy. Polymer 1997; 38: 43–51
   Web of Science ®Google Scholar
• Smrdel P, Bogataj M, Podlogar F, Planinšek O, Zajc N, Mazaj M, Kaučič V, Mrhar M. Characterisation of calcium alginate beads containing structurally similar drugs. Drug Dev Ind Pharm 2006; 32: 623–633
   PubMed Web of Science ®Google Scholar
• Sriamornsak P, Nunthanid J. Calcium pectinate gel beads for controlled release drug delivery: II. Effect of formulation and processing variables on drug release. J Microencapsulation 1999; 16: 303–313
   PubMed Web of Science ®Google Scholar
• Takka S, Acartürk F. Calcium alginate microparticles for oral administration: III. The effect of crosslink agents and various additive polymers on drug release and drug entrapment efficiency. Die Pharmazie 1999; 54: 137–139
   Web of Science ®Google Scholar
• Tateshita K, Sugawara S, Imai T, Otagiri M. Preparation and evaluation of a controlled-release formulation of nifedipin using alginate gel beads. Biol Pharm Bull 1993; 4: 420–424
   Google Scholar
• Tønnesen HH, Karlsen J. Alginate in drug delivery systems. Drug Dev Ind Pharm 2002; 28: 621–630
   PubMed Web of Science ®Google Scholar
• Tze Fung Tan Y, Khiang Peh K, Al-Hnbali O. Investigation of interpolymer complexation between Carbopol and various grades of polyvinylpyrrolidone and effects on adhesion strength and swelling properties. J Pharm Pharm Sci 2001; 4: 7–14
   PubMedGoogle Scholar
• Urleb U, Krbavčič A, Sollner Dolenc M, Kikelj D, Pečar S. Synthesis of phtalimido-desmuramylpeptide analogues as potential immunomodulating agents. Archiv der Pharmazie 1995; 328: 113–117
   PubMed Web of Science ®Google Scholar
• Vandamme TH, Lenourry A, Charrueau C, Chaumeil JC. The use of polysaccharides to target drugs to the colon. Carbohyd Polym 2002; 48: 219–231
   Web of Science ®Google Scholar
• Velings MN, Mestdagh MM. Physico-chemical properties of alginate gel beads. Polym Gels Networks 1995; 3: 311–330
   Google Scholar
• Yoneda F, Muraoka S, Moriguchi M, Norisada N, Ochi C, Stalc A. 2001, Lavric, A, Urleb U. 2001. Anti-inflammatory pharmaceutical preparations. Patent WO 01/35987, 25 May
   Google Scholar
• Zohar-Perez C, Chet I, Nussinovitch A. Irregular textural features of dried alginate-filler beads. Food Hydrocoll 2004; 18: 249–258
   Web of Science ®Google Scholar